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Fesselin is an intrinsically disordered protein that is known to bind a large variety 
of cytoskeletal proteins. The proteins fesselin is known to bind include: actin (Leinweber 
et al. 1999), α-actinin (Pham et al. 2006), calmodulin (Schroeter et al. 2004), filamin 
(Weins et al. 2001), and smooth myosin (Schroeter et al. 2005). The binding of fessilin 
to smooth myosin is of particular interest because unphosphorylated smooth muscle 
myosin filaments are unstable in the presence of ATP (Trybus et al. 1982, Ikebe et al. 
1983, Suzuki et al. 1978). However, in smooth muscle cells unphosphorylated myosin 
filaments are maintained (Milton et al. 2011). Several proteins have been identified that 
stabilize myosin filaments and actin-myosin filament interactions. Our experiments show 
that fesselin may be one such protein.  
The organization of F-actin and myosin filaments by fesselin was observed by 
monitoring the rate of dissociation of actin-myosin by ATP in a stopped-flow device. 
Actin-myosin dissociation was measured by light scattering (a measure of particle size) 
and by pyrene-actin or acrylodan-tropomyosin fluorescence (a measure of myosin-actin 
bond breaking). The stopped-flow studies were further supported with electron 
 
 
microscopy analysis. These experiments showed that fesselin was able to tether actin 
and myosin filaments together without significantly impacting the rate of the actin-
myosin bond breaking. 
The stabilization of myosin filaments by fesselin was tested using a similar 
method. First, stopped-flow rapid kinetics was used to measure the rate of ATP induced 
myosin filament break down. Next, electron microscopy was used to support the 
stopped-flow data and observe the effects of fesselin on myosin filament organization. 
Through the stopped-flow and electron microscopy experiments it was found that 
fesselin stabilizes myosin filaments. The electron microscopy experiments further 
revealed that fesselin enhanced myosin filament size and organized them into bundles. 
Previously published results showed that the interaction between fesselin and 
actin is regulated by calmodulin (Schroeter et al. 2004). The final set of experiments 
presented here examined the possibility that calmodulin regulates the interactions 
between fessilin and myosin. The calmodulin regulation of fesselin myosin interactions 
would greatly expand the role that fesselin has within smooth muscle by placing it within 
the calcium signaling pathway. The regulation of fesselin-myosin interactions by 
calmodulin was tested using pyrene labeled actin as well as N,N'-Dimethyl-N-
(Iodoacetyl)-N'-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Ethylenediamine labeled fesselin 
(IANBD-fesselin). These experiments showed that the interactions between fesselin and 
myosin are regulated by calmodulin. Overall, our results support that fesselin plays a 
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Within humans there are three major types of muscle: skeletal, cardiac, and 
smooth. Skeletal and cardiac muscles have striations that result from the highly ordered 
myosin and actin filaments. The structural organization of actin and myosin in smooth 
muscle and non-muscle cells is less obvious. However, it is certain, that myosin and 
actin must exist in their filamentous states and these filaments must be in close physical 
proximity to each other for contraction to occur. Striated muscles contain a bevy of 
proteins that stabilize and organize the filaments. There is also a group of proteins 
within smooth and non-muscle cells that organize actin and myosin and hold them in 
close association with each other. We propose that the protein fesselin, discovered in 
our laboratory, stabilizes actin and myosin filament and organizes these filaments into 
contractile units.  
 
Fesselin is an Intrinsically Disordered Protein 
Fesselin was first isolated from avian smooth muscle (Leinweber et al. 1999, 
Schroeter et al. 2008). Fesselin is proline rich protein with a pI near 9.3 (Leinweber et 
al. 1999).  The proline residues and negatively charged residues produce a protein that 
is intrinsically disordered (Khaymina et al. 2007).  
Intrinsically disordered proteins (IDP) typically have roles in signaling, 
transcription, and chromatin remodeling. This type of protein can also provide flexible 
linkers between parts of a complex, and the IDP act as adaptors for their ligands.  
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To visualize an intrinsically disordered protein, such as fesselin, one could 
picture a length of rope, while a typically structured protein can be thought of as a 
basket. Following this analogy, the target ligands can be thought of as group of sticks of 
various lengths. The basket, or typically structured protein, could be used to quickly and 
easily hold some of the sticks, as long as they are of short enough length to fit inside. 
For the sticks that are too large, a whole new basket would be needed. In the case of 
our intrinsically disordered protein, or rope, any of the sticks can be carried regardless 
of length, but it would require more time to gather the sticks and lash them together. 
Typically structured proteins are adept at dealing with their target ligand but have a 
smaller range of targets. Intrinsically disordered proteins require more time and energy 
to bind their ligands. This is due to the fact that many intrinsically disordered proteins 
undergo folding as they bind their target. This fact allows intrinsically disordered 
proteins to have a large range of ligands. Fessein is known to bind to actin (Leinweber 
et al. 1999) desmin (Renegar et al. 2009), α-actinin (Pham et al. 2006), zyxin 
(Linnemann 2010), calmodulin (Schroeter et al. 2004, Kolakowski et al. 2004), and 
smooth muscle myosin (Schroeter et al. 2005). This list of binding partners is likely to 
grow.  
 
Disease related roles of fesselin 
Other labs have shown that isoforms of fesselin play roles within cancer 
metastasis. When fesselin isoforms are found in the cytoplasm of cancer cells, it 
correlates with more metastatic cancer (Stevenson et al. 2012). These studies found the 
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heightened metastatic behavior was due to the promotion of actin bundle formation (Kai 
et al. 2013, Stevenson et al. 2012). 
The heightened metastatic behavior of cancer cells with fesselin seems to be due 
to an up regulation of fesselin leading to more organized contractile systems and thus 
more motility. The opposite is true for the interactions of fesselin isoforms and duchenne 
muscular dystrophy (DMD). Within skeletal muscle cells cultured from patients with 
DMD, the expression of the human skeletal isoform of fesselin is down regulated 
(Tkatchenko et al. 2001).  
Like all forms of muscular dystrophy, DMD is caused by a lack of organization of the 
muscle tissue. The disruption of organization is caused by problems with expression or 
activity of dystrophin. DMD is one of the most common forms of muscular dystrophy as 
well as the most severe. The decrease in the skeletal isoform of fesselin may be related 
to the severity of Duchenne muscular dystrophy. Previous groups found that the skeletal 
isoform of fesselin is expressed very early in differentiating muscle cells and likely plays 
a critical role in actin organization (Linnemann et al. 2010).  
 
Cellular Localization of Fesselin is consistent with a role in actin organization. 
Antibody-staining of avian smooth muscle tissue revealed that fesselin was 
localized to the dense bodies (Renegar et al. 2009). Within smooth muscle the dense 
bodies are the actin organizing centers that connect the contractile actin filaments to the 
cell membrane. Through these structures the force produced by myosin filaments 




Fesselin polymerizes and bundles actin 
The localization of fesselin to the dense bodies of smooth muscle showed that 
fesselin likely plays a critical role in F-actin filament organization. To polymerize F-actin 
filaments one F-actin monomer needs to bind with two other F-actin monomers to form 
an actin nuclei for filament growth. The formation of actin nuclei is the rate-limiting step 
for F-actin filament polymerization. 
Fesselin binds actin monomers, and aids in its polymerization to F-actin filaments 
by stabilizing the actin nuclei (Beall et al. 2001, Leinweber et al. 1999). In addition 
fesselin was also shown to bundle F-actin filaments together (Schroeter et al. 2013). F-
actin bundles are a required structure to make contraction possible as the bundles form 
a rigid support for the myosin to apply force. 
The next finding involving fesselin and actin was the regulation of actin 
polymerization in the presence of calmodulin. Experiments were performed using 
pyrene-labeled-actin with fesselin and calmodulin. In these studies it was found that the 
polymerization of G-actin to F-actin filaments by fesselin was regulated by calmodulin 
(Schroeter et al. 2004, Kolakowski et al. 2004). 
 
Fesselin binding to myosin suggests a broader role within smooth muscle 
Dr. Schroeter observed that fesselin displaced myosin from actin (Schroeter et al. 
2005).  This is a common observation for actin binding proteins because they typically 
bind at a common site near the target-binding cleft of actin between domains 1 and 3 
(Dominguez et al. 2011). Dr. Schroeter also observed evidence that fesselin bound 
directly to myosin, at a ratio of two myosin to one fesselin (Schroeter et al. 2005). The 
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direct binding to multiple myosin molecules by fesselin expanded the possible role for 
fesselin from an actin binding protein to one that organized the contractile apparatus of 
the cell. 
Because of the requirement for proteins to stabilize actin-myosin interactions in 
relaxed muscle, we tested the possibility that fesselin organized contractile elements 
composed of both actin and myosin.  That is, we investigated the possibility that fesselin 
stimulates the formation of actin bundles from G-actin, stabilizes myosin filaments and 
stabilizes actin bundle-myosin bundle associations. Investigating the function of fesselin 
in smooth muscle myosin is complex because this myosin is regulated by 
phosphorylation and forms inactive and active structures.   
 
Smooth muscle myosin conformations and filament formation 
In smooth muscle, the activity of myosin is modulated by the phosphorylation 
state of the regulatory light chains. Figure 1 shows a representation of the regulation of 
the smooth myosin conformational shift. Phosphorylation of the regulatory light chain of 
smooth myosin promotes the 6S conformer and thus the formation of myosin filaments. 
The calcium-signaling pathway (figure 2) leads to the phosphorylation of smooth myosin 
light chains and formation of functional myosin filaments. Within non-muscle and some 


















The regulation of smooth muscle myosin includes conformational shifts of the myosin. 
The conformation of smooth myosin determines the activity of the protein. Smooth 
myosin conformation is controlled mainly through two factors: ionic strength and 
phosphorylation state. The shift from 10s (inactive) to 6s (active) is promoted by 
lowering the ionic strength and/or phosphorylation of the light chains. Formation of 
myosin filaments requires moving to the 6s conformation. Increasing ionic strength or 


















A simplified schematic of smooth muscle regulation. Calcium channels on the cell allow 
intracellular calcium ion increase. The calcium then binds to calmodulin. Calcium-
calmodulin activates myosin light chain kinase (MLCK). Then MLCK phosphorylates the 
regulatory light chain of smooth myosin (MLC). The phosphorylation promotes myosin 
filament stability and the filament capable form of smooth myosin. The phosphorylated 




Smooth muscle myosin is stabilized by several proteins in smooth muscle 
As presented in figure 1 the formation of smooth myosin filaments is controlled through 
two major factors: phosphorylation of the regulatory light chains and ionic strength. 
Smooth myosin forms filaments when the regulatory light chains are phosphorylated or 
when the ionic strength is near 0.15 M KCl (Trybus 1982). The presence of 
phosphorylated smooth myosin filaments in smooth muscle is unsurprising as 
phosphorylation promotes smooth myosin filament formation. A surprising finding was 
the presence of unphosphorylated myosin filaments within smooth muscle (Somylo et 
al. 1981). In vitro studies found that unphosphorylated smooth myosin filaments 
depolymerized in the presence of stoichiometric amounts of ATP (Onishi et al. 1978). It 
was noted that the myosin from filaments disassembled by ATP had a far lower ATPase 
rate than myosin disassembled by high salt (Suzuki et al. 1978). Other groups 
performed studies to monitor what changes occurred when ATP bound the myosin. It 
was found that upon binding to the unphosphorylated myosin, the ATP caused the 
myosin to disassemble into the inactive 10S conformation (Trybus et al. 1982). This 
finding was further confirmed by monitoring tryptophan fluorescence changes induced 
by ATP binding the myosin (Ikebe et al. 1983). The observation of unphosphorylated 
myosin filaments in smooth muscle taken into account with the in-vitro work leads to the 
conclusion that there is something stabilizing the unphosphorylated myosin filaments. 
The simple answer is an interaction between a myosin binding protein and the 
unphosphorylated smooth myosin that stabilizes the myosin filaments. 
There have been several different proteins proposed to stabilize 
unphosphorylated smooth myosin filaments. Some proteins like telokin are proposed to 
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bind to 10S myosin and promote the transition to the 6S conformation (Kudryashov et 
al. 2002).  The interaction of telokin with unphosphorylated smooth myosin aids in the 
formation of filaments and stabilizes the filaments against ATP-induced disassembly 
(Katayama et al. 1995). The interaction between telokin and smooth myosin is not 
unlike how myosin light chain kinase interacts with smooth myosin, this is because 
telokin is identical in structure to the C-terminus of myosin light chain kinase (Holden et 
al. 1992). Other proteins have been found to stabilize unphosphorylated smooth myosin 
filaments against ATP induced disassembly. One such protein is caldesmon (Katayama 
et al. 1995). Caldesmon was shown to bind several heavy meromyosin molecules 
together and stabilize myosin filaments (Marston et al. 1989). These observations lead 
to the conclusion that caldesmon binds across multiple smooth myosin molecules to 
stabilize the unphosphorylated smooth myosin filaments (Katayama et al. 1995). 
We propose that fesselin interacts with smooth myosin in much the same way 
that caldesmon does, binding to myosin filaments and stabilizing them. The findings of 
Schroeter et al. support this method of interaction in that one fesselin binds to two 
myosin molecules (2005).  
 
Several proteins are known to cross-link actin and myosin. 
The direct linking between F-actin and myosin filaments is a simple way to keep 
the contractile filaments in association and organized for force production. There are a 
variety of proteins found within multiple muscle types that cross-link actin and myosin. 
Myosin-binding protein-C has been found to cross-link myosin and F-actin filaments 
together in striated muscle (Luther et al. 2011). This same cross-linking of actin and 
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myosin has been attributed to caldesmon as well as calponin in smooth muscle (Ikebe 
et al. 1988, Marston et al. 1992, Chalovich et al. 1988, Roman et al. 2013). The lack of 
a well-defined sarcomere within smooth muscle makes this cross-linking activity all the 
more important to the organization of actin and myosin filaments. This is because the 
sarcomere provides a rigid structure to hold the actin and myosin filaments in 
association. The cross-linking of F-actin and myosin filaments in smooth muscle is a 
viable solution to the organizational problem presented by a lack of a well-defined 
sarcomere. We propose that fesselin displays a similar activity to caldesmon and 
calponin by cross-linking F-actin and myosin filaments. 
 
HYPOTHESIS: Fesselin binds to and organizes smooth myosin and holds actin 
and myosin together.  
Because of its role in actin bundle formation and its binding to myosin, we 
propose that fesselin organizes smooth myosin and cross-links F-actin and myosin 
filaments. Figure 3 shows the proposed functions of fesselin alongside the previously 
known interactions. Figure 3 A shows the binding of fesselin to G-actin. The figure also 
shows formation of an F-actin nuclei and polymerization of F-actin filaments. This 
section further shows the formation of F-actin bundles from the filaments. Figure 3 B 
shows our proposed interaction between F-actin filaments and smooth myosin. This 
proposed interaction would fill the role of holding the actin and myosin filaments in 
association to facilitate productive contraction. Figure 3 C shows a proposed interaction 
between fesselin and smooth myosin alone. This takes into account the fesselin-actin 
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interactions and applies them to myosin. This proposed activity would aid in the 















Proposed activities of fesselin with actin and myosin. A) Fesselin’s known interactions 
with actin. Fesselin binds to actin and accelerates the polymerization, the acceleration is 
regulated by calcium calmodulin. The fesselin further interacts with actin filaments and 
bundles them. B) The proposed interaction between fesselin and actin-myosin. C) The 
proposed interactions of fesselin with myosin. This proposed activity is based on 
interactions of similar proteins and the affinity of fesselin for myosin. 
 Materials and Methods 
Fesselin Preparation 
The fesselin used in the studies presented here was isolated from frozen turkey 
gizzards. The gizzards were trimmed of connective tissue and diced into roughly one-
inch pieces prior to freezing in liquid nitrogen. From the frozen gizzards two methods of 
fesselin preparation were compared.  
The first method was based on the original procedure of Leinweber et al. (1999). 
200 g of frozen turkey gizzards that were ground in a precooled meat grinder and 
transferred directly to a 1 L ice cold buffer (300 mM KCl, 50 mM MOPS pH 7.0, 0.5 mM 
Phenylmethanesulfonyl fluoride (PMSF), 0.75 mM bezamidine (0.12 g/L), soybean 
trypsin inhibitor, 5 mg leupeptin, protease inhibitor cocktail (0.5 mL prepared to 
manufacturer specifications SIGMA P2714). 
The ground turkey gizzard mixture was then homogenized on ice in a Brinkmann 
homogenizer (model PCU7) 4 times for 10 seconds each. The homogeneous mixture 
was then heated in a 100° C water bath in 300-400 mL aliquots for 8 – 9 minutes while 
stirring. Heating continued until the mixture had separated into two layers.  
After heat treatment, the mixture was moved to a pre-cooled vessel on ice and 
rapidly cooled. After 15 minutes, further protease inhibitors were added (SIGMA P2714 
protease inhibitor cocktail). After a further 15 minutes, dithiolthreitol (DTT) was added to 
a final concentration of 1 mM. The mixture was then centrifuged (23,000 g, 30 minutes, 
4° C) and the supernatant collected and filtered through glass wool.  
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Ammonium sulfate was added to the clarified supernatant to a final concentration 
of 30% (176 g/L) and allowed to stir at 4°C for several hours. After stirring, the mixture 
was centrifuged (13,000 g, 30 minutes, 4°C) and the protein pellets collected. These 
pellets were dissolved in a minimum volume (~20 mL) of buffer composed of: 6 M urea, 
20 mM Na-Acetate pH 5.6, 2 mM EDTA, 2 mM EGTA, 1 M NaCl, 0.5mM DTT, 0.5mM 
PMSF. To the solubilized pellets, 50 mg of soybean trypsin inhibitor was added. This 
mixture was then dialyzed twice against a buffer composed of: 6 M urea, 20 mM Na-
Acetate pH 5.6, 2 mM EDTA, 2 mM EGTA, 0.5 mM DTT, 0.5 mM PMSF. 
The dialysate was clarified by centrifugation (140,000 g, 40 minutes, 4°C) prior to 
loading it onto a pre-equilibrated with urea buffer: (6 M urea, 20 mM Na-Acetate pH 5.6, 
2 mM EDTA, 2 mM EGTA, 0.5 mM DTT, 0.5 mM PMSF) CM-500 column (100 mL 
volume column) (figure 4 a). The column was washed with 2 – 3 column volumes of 
urea buffer before eluting with a linear KCl gradient (0 - 300 mM). The fractions were 
analyzed first by absorbance at 280 nm, and then the relevant fractions were run on a 
12% SDS-PAGE gel (figure 4 b). The fractions containing the 103 kD and 79 kD 
polypeptides of fesselin were pooled and dialyzed against a buffer composed of: 100 
mM KCl, 10 mM MOPS pH 7.2, 2 mM EDTA, 2 mM EGTA, 1 mM DTT, 0.5 mM PMSF.  
The dialysate was then loaded onto a pre-equilibrated with KCl buffer (100 mM 
KCl, 10 mM MOPS pH 7.2, 2 mM EDTA, 2 mM EGTA, 1 mM DTT, 0.5 mM PMSF) CM-
500 column (25 mL volume column). The column was washed with 2 – 3 column 
volumes of KCl buffer (or until absorbance reached zero) before eluting with a linear KCl 
gradient (100 - 300 mM). The fractions were analyzed by SDS-PAGE and western blot 
prior to further dialysis (figure 4 c).  
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The fractions containing the fesselin polypeptides were further purified using a 
calmodulin affinity column equilibrated with: 50 mM KCl, 20 mM Tris-HCl pH 7.4, 2 mM 
MgCl2, 0.5 mM CaCl2, 1 mM DTT. The affinity column was washed with buffer 
supplemented with 0.5 M KCl. After washing, the fesselin was eluted from the column 
with a buffer composed of: 50 mM KCl, 20 mM Tris-HCl pH 7.4, 2 mM MgCl2, 1 mM 
EDTA, 1 mM EGTA, 1 mM DTT. The column was then further washed with the 
EDTA/EGTA buffer supplemented with 0.5 M KCl. The fractions were analyzed by SDS-
PAGE before flash freezing the fractions containing fesselin (figure 4 d). This 
preparation yielded 5 mg of ~90% pure fesselin ranging in concentration from 0.3 
mg/mL to 0.9 mg/mL. The concentrations were calculated from absorbance readings at 
280 nm. 
 
Fesselin purification method 2 
The second method used for fesselin preparation was developed based on the 
Kolakowski (2004) method. This differed in the initial stages and in the ion exchange 
resin used for purification. 
200 g of frozen turkey gizzards were transferred to heat seal bags and heated in 
a 100° C water bath for 5 – 7 minutes or until the meat browned. The gizzards were 
then ground in a pre-cooled meat grinder. To the ground gizzards, 1 L of ice-cold buffer 
was added (300 mM KCl, 50 mM MOPS pH 7.0, 0.5 mM PMSF, 0.75 mM bezamidine 
(0.12 g/L), 5 mg soybean trypsin inhibitor, 1 mg leupeptin, 0.5 mL Protease Inhibitor 
Cocktail (prepared to manufacturer specifications) (SIGMA P2714)).  
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The ground turkey gizzard mixture was then homogenized on ice in a 
Brinkmann homogenizer (model PCU7) 4 times for 10 seconds each. The mixture was 
then centrifuged (23,000 g, 30 minutes, 4° C) and the supernatant collected and filtered 
through glass wool. 
Ammonium sulfate was added to the clarified supernatant to a final 
concentration of 30% (176 g/L) and allowed to stir at 4°C for several hours. After 
stirring, the mixture was centrifuged (13,000 g, 30 minutes, 4°C) and the protein pellets 
collected. These pellets were dissolved in a minimum volume (~20 mL) of buffer 
composed of: 6 M urea, 20 mM Na-Acetate pH 5.6, 2 mM EDTA, 2 mM EGTA, 1 M 
NaCl, 0.5mM DTT, 0.5mM PMSF. 
The pellets were then dialyzed twice against 1L of: 6M urea, 10 mM Tris-HCl pH 
8.5, 2 mM MgCl2, 1 mM EGTA, 1 mM DTT.  
The dialysate was then clarified by centrifugation (140,000 g, 40 minutes, 4°C) 
before loading onto a pre-equilibrated with the same buffer as the previous dialysis SP-
Sephadex column (60 mL volume column). The column was washed with 2 – 3 column 
volumes of the equilibration buffer supplemented with 30 mM KCl. After washing the 
column was eluted using a linear KCl gradient (30 - 300 mM). The fractions were 
analyzed first by absorbance at 280 nm, and the relevant fractions were run on a 12% 
SDS-PAGE gel. The fractions containing the 103 kD and 79 kD polypeptides of fesselin 
were pooled and dialyzed against: 50 mM KCl, 20 mM Tris-HCl pH 7.4, 2 mM MgCl2,1 
mM DTT.  
CaCl2 was added to the dialysate to a final concentration of 0.5 mM and applied to a 
calmodulin affinity column pre-equilibrated with Calcium buffer (50 mM KCl, 20 mM Tris-
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HCl pH 7.4, 2 mM MgCl2,0.5 mM CaCl2, 1 mM DTT). The affinity column was washed 
with calcium buffer supplemented with 0.5 M KCl. After washing the fesselin was eluted 
from the column using EDTA/EGTA buffer (50 mM KCl, 20 mM Tris-HCl pH 7.4, 2 mM 
MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT). The column was then further washed 
with the EDTA/EGTA buffer supplemented with 0.5 M KCl. The fractions were analyzed 
by SDS-PAGE before flash freezing the fractions containing fesselin. This preparation 
yielded 10 mg of ~90% pure fesselin ranging in concentration from 0.5 mg/mL to 0.7 
mg/mL. The concentrations were calculated from absorbance readings at 280 nm. 
Both of these methods were used to purify fesselin and yield identical purity and 
activity of products, but the second method takes less time (3 days rather that 10) and 














Fesselin purification requires multiple steps. Because of the activity of the fesselin 
purifying it away from contaminants is an involved process. (a) Post ammonium sulfate 
precipitation. (b) Post CM-500 column I, the fesselin was identifiable but there are still 
several high and low molecular weight contaminants. (c) Post CM-500 column II. The 
higher molecular weight bands are likely aggregated fesselin considering they react to 
fesselin antibody (data not shown). (d) Post calmodulin affinity purification. The bands 





Smooth muscle myosin preparation 
Smooth muscle myosin was prepared from frozen turkey gizzards using a 
modified method from Persechini (1983), and Sobieszek (1975). 150 g of turkey 
gizzards (chilled to near freezing) were ground twice using a pre-cooled meat grinder 
and suspended in 3 volumes (compared to the ground gizzards) of wash buffer (50 mM 
KCl, 10 mM Tris-HCl pH 7.6, 2 mM EGTA, 15 mM MgSO4, 0.2 mM DTT, 0.1% vol Triton 
X-100).  
The mixture was then homogenized for 3 - 5 seconds using a Brinkmann 
homogenizer. The pellet was recovered by centrifugation (7,500 g, 10 minutes, 4°C) 
and 3 more volumes of buffer were added. Homogenization and centrifugation was 
repeated 4 times with wash buffer and a further 4 times using wash buffer without triton 
X-100. After completion of the final centrifugation the pellets were homogenized in 600 
mL of: 40 mM imidazole pH 7.15, 8 mM ATP, 60 mM KCl, 1 mM EDTA, 100 mg/L 
streptomycin, 0.5 mM DTT. The homogenization was carried out 3 times for 5 seconds. 
The supernatant was then collected by centrifugation (14,500 g, 20 minutes, 4°C).  
After centrifugation, the supernatant was filtered through glass wool. Next 0.18 
volumes of 1M MgSO4 were added (volume calculated from volume of clarified 
supernatant) using a peristaltic pump at a rate of 1 mL/min. Then ATP was added to a 
final concentration of 2.5 mM. This mixture was allowed to sit for 10 minutes at room 
temperature before collecting the supernatant by centrifugation (14,500 g, 10 minutes, 
4°C). The supernatant was then filtered through glass wool and centrifuged for 8 hours 
(40,000 g, 4° C).  
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The supernatant from the 8 hour centrifugation was then slowly diluted with 10 
volumes of ice-cold water. The diluted crude myosin was allowed to sit for at least 2 
hours at 4°C. After the myosin precipitated in the water, the pellet was recovered by 
centrifugation (14,500 g, 15 minutes, 4°C). The protein containing pellet was then 
suspended in 1 volume of water with a glass/Teflon homogenizer (volumes based on 
the pellet). Next at 4°C 0.0038 volumes of 100 mM EGTA were added. Then 0.05 
volumes of Na2HPO4, pH 7.6 were added. Then 0.25 volumes of 1 M MgSO4 were 
added. Finally 0.063 volumes of 100 mM ATP were added. All of these additions were 
done slowly using a peristaltic pump (0.5 mL/min). 
The mixture was then allowed to stand for 10 minutes at 4°C. The supernatant 
was then separated and collected using centrifugation (150,000 g, 2 hours, 4° C). The 
supernatant was then diluted with 10 volumes of ice-cold water. The myosin precipitate 
was then collected by centrifugation (23,000 g, 15 minutes, 4° C). The collected myosin 
pellets were dissolved in a minimum volume of: 0.3 M KCl, 10 mM Tris-HCl pH 7.6, and 
0.2 mM DTT.  
To further purify the myosin it was loaded onto a Sepharose 4B column that was 
equilibrated with a buffer composed of: 0.3 M KCl, 10 mM Tris-HCl pH 7.6, and 0.2 mM 
DTT. Prior to loading onto the column the myosin was diluted to 3.5 mg/mL. To prevent 
phosphorylation of the myosin light chains 0.5 mM EGTA was added to the buffer. This 
preparation yielded 0.5 - 1 g of purified myosin which could be used immediately or 





Actin was purified from acetone powders generated from rabbit erector spinae 
muscle. This method is based on Ebashi (1965). 9 grams of acetone powder were 
added to 270 mL of Extraction buffer (0.5 mM ATP, 2 mM Tris-HCl pH 7.8, 0.1 mM 
CaCl2, 1 mM β-mercaptoethanol) extraction was carried out on ice. The actin was gently 
stirred once every 10 min for a total of 30 min as to reduce the extraction of 
contaminating proteins such as α-actinin or tropomyosin.  
The supernatant was then collected by centrifugation (47,000 g, 45 minutes, 4°C) 
and filtered through glass wool. Solid KCl was then added to the supernatant to a final 
concentration of 3.3 M. The KCl addition was carried out at room temperature with 
stirring until the solution reaches 15°C. The solution was then cooled to 5°C.  
The supernatant was then clarified by centrifugation (47,000 g, 45 minutes, 4°C). 
The supernatant was then dialyzed against 32 volumes of: 2 mM Tris-HCl pH 7.6, 1 mM 
MgCl2.  
After dialysis 4 M KCl was added to the dialysate to give a final concentration of 
0.8 M. This was allowed to stir at 4°C for 1 hour. The pellets were then collected using 
centrifugation (147,000 g, 90 minutes, 4° C), dissolved in 25 mL of the extraction buffer 
then homogenized with a glass/Teflon homogenizer. The resuspended pellets were 
then dialyzed against 2 exchanges of at least 20 volumes of extraction buffer. 
The actin was then placed in a beaker and stirred while adding imidazole to 10 
mM and MgCl2 to 1 mM. The solution was then dialyzed at 4° C against 2 exchanges of 
20 volumes of: 4 mM imidazole pH 7.0, 2 mM MgCl2, 0.5 mM ATP. To store the actin at 
4°C NaN3 was added to 0.01% directly to the actin. This preparation yielded 100-180 




Myosin and Calmodulin Affinity columns 
Affinity columns were prepared from lyophilized CNBr-activated sepharose-4B 
resin according to manufacturer’s instructions (GE Healthcare 71-7086-00 AF). The 
resin was weighed out according to the manufacturers specifications (1g = ~3.5 mL) for 
the myosin subfragment columns between 0.5 – 2 mL final volume of resin was used.  
Prior to the preparation of the resin, the desired ligand was dialyzed into the 
coupling buffer (0.5 M NaCl .1 M NaHCO3 pH 8.4) which facilitates the CNBr reaction 
and subsequent covelent bonding of the protein to the sepharose beads. The amount of 
ligand was added at 5 mg/mL of swollen resin.  
The weighed out dry resin was washed and allowed to swell in 1 mM HCl. This 
swelling and washing was critical to wash away stabilizing compounds in the resin and 
prepare it for coupling. After the resin swelled for 15 minutes it was further rinsed with 1 
mM HCl (200 mL/g of dry resin) and then 2 column volumes of milli-Q water. 
The resin was immediately mixed with the ligand in a vial with adequate volume 
for inversion mixing using a rocking mixer to avoid damaging the protein or the 
sepharose beads. For the calmodulin affinity columns mixing, was at room temperature 
for 1 hr. For the myosin and myosin-subfragment columns, mixing was at 4°C for 16 
hours. The buffer was decanted and the remaining CNBr activated beads were blocked 
with 1 M ethanolamine pH 8.0. The ethanolamine was added directly to the resin and 
allowed to block for 1 hour at room temperature for calmodulin columns or for 16 hrs at 
4°C for the Myosin and Myosin subfragment columns. 
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The resin was transferred to a column and rinsed with 2 column volumes of 
coupling buffer. To remove any unreacted calmodulin. The calmodulin resin was rinsed 
with coupling buffer (0.5 M NaCl, 0.1 M NaHCO3, pH 8.4), followed by acetate buffer 
(0.5 M NaCl, 0.1 M Na-Acetate, pH 4.0). For the myosin and myosin subfragments, the 
columns were rinsed with only coupling buffer in a far greater volume (10 column 
volumes minimum). 
To determine the efficiency of coupling, a small sample of resin was tested using 
a Bradford colorimetric assay. This was controlled using resin reacted with 
ethanolamine alone and the eluted protein from the reaction as well as other protein 
standards. 
 
Fluorescent labeled proteins 
For several of the studies presented here, fluorescently labeled proteins were 
utilized. All of the reagents used involved an iodoacetamide conjugation to covalently 
link the fluorophore to a cysteine residue on the target protein. 
 
IANBD fesselin 
Turkey gizzard fesselin was labeled with N,N'-Dimethyl-N-(Iodoacetyl)-N'-(7-
Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Ethylenediamine (IANBD) using a 5 fold molar excess 
for 12 hours at 4°C.  
The fesselin was first reduced by adding DTT to a concentration of 2 mM then 
dialyzing the fesselin against 3 exchanges of 100 volumes of: 85 mM NaCl, 15 mM 
Na2HPO4 pH 7.0. The IANBD was prepared at a stock concentration of 10 mg/mL in 
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dimethylformamide (DMF). The IANBD was added at 5 - fold molar excess to the 
fesselin with very rapid mixing. The mixing was required to minimize the damage that 
the DMF did to the fesselin. After mixing the probe with the fesselin, the vial was 
covered and light protected.  
This reaction was allowed to sit at 4°C for 12 hours. After 12 hours DTT was 
added to 2 mM final concentration to quench the reaction. The unreacted probe was 
removed by centrifugation (120,000 g, 40 minutes, 4°C). The extent of labeling was 
determined using a UV-Vis spectrophotometer scanning from 600 to 250 nm. Labeled 
IANBD absorbs at 492 nm, the extinction coefficient for IANBD in water is 21,000 cm-1, 
M-1. For fesselin an extinction coefficient of 1 at 280 nm was used for initial estimation of 
concentration, and a Bradford or Lowry assay was used for a further determination.  
Under the conditions presented here, the extent of labeling was on average of 
5:1 label : protein. 
 
Acrylodan tropomyosin 
Tropomyosin was reduced prior to labeling in a buffer of: 100 mM KCl, 10 mM 
Na2HPO4 (pH 6.5), 5 mM EDTA, 1 mM dithiolthreitol (DTT). After dialysis additional 
Na2HPO4 was added to bring concentration up to 50 mM and DTT was added to a final 
concentration of 10 mM. After this addition the tropomyosin was allowed to incubate at 
37°C for 30 minutes.  
Post incubation the tropomyosin was dialyzed twice against 500 mL of: 3 mM 
MOPS pH 7.5, 0.1 mM EDTA. Guanidine HCl was added to a final concentration of 4 M. 
a 5-fold molar excess of 6-Acryloyl-2-Dimethylaminonaphthalene (acrylodan) was 
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added and allowed to react for 8 hrs at room temperature, in the dark under a nitrogen 
atmosphere. Adding excess DTT was used to quench the reaction.  
The unreacted probe was removed by centrifugation (120,000, 20 minutes, 4°C) 
and the supernatant was retained. Post centrifugation, the supernatant was dialyzed 
against 20 volumes of 4 M guanidine HCl, 3 mM MOPS pH 7.5, 0.1 mM EDTA. 
Tropomyosin was further dialyzed twice against 15 volumes of 40 mM NaCl, 5 mM 
MOPS pH 7.5, 0.2 mM EDTA, 0.01% NaN3. The extent of labeling was then determined 
using a UV/vis spectrophotometer scanning from 600 to 250 nm. The determination 
used the extinction coefficient for acrylodan at 372 nm of 14,400 cm-1, M-1 and an 
extinction coefficient of 0.75 ε 0.1% at 280 nm for tropomyosin. The labeling efficiency for 
this preparation was 70 – 80% 1 label : 1 tropomyosin. 
 
Pyrene actin 
Pyrenyl-iodoacetamide labeled actin was prepared from f-actin in actin buffer: 4 
mM imidazole pH 7.0, 2 mM MgCl2. Actin was diluted to 2 mg/mL, dilution buffer (100 
mM Tris pH 8.0, 1 M KCl, 20 mM MgCl2, 1 mM CaCl2, 0.1% NaN3) accounted for 10% 
of the final volume (e.g. 20 mg actin, 1 mL dilution buffer, 9 mL H2O) and stirred until a 
homogeneous mixture.  
Pyrenyl-iodoacetamide (pyrene) was prepared at a concentration of 14 mg/mL in 
DMF. The pyrene solution was then added to the actin in the dark and allowed to 
incubate for 12 hrs at 4°C. DTT was added to quench the reaction.  
The actin was then centrifuged to remove unreacted pyrene (140,000 g, 20 min, 
4°C). F-actin was then recovered by centrifugation (145,000 g, 1 hr, 4°C). The pellets 
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contained the pyrene-labeled actin; these were homogenized and dialyzed against 500 
mL of actin buffer. The extent of labeling was then determined using a UV/vis 
spectrophotometer scanning from 600 to 250 nm. The determination used the extinction 
coefficient for pyrene at 344 nm of 22,000 cm-1, M-1 and a lowry assay for the actin. The 
labeling efficiency for this preparation was 80% 1 pyrene : 1 actin. 
 
Protein cross-linking 
The crosslinking reaction buffer used was: 85 mM NaCl, 15 mM Na2HPO4 pH 
7.4. This same buffer composition was used for all the cross-linking reagents For the 
primary amine reactive reagents Tris buffer was added to quench unreacted cross-
linker. To quench the cysteine reactive reagents, DTT was added.  
For non-UV activated cross-linkers, the incubation time varied slightly. 3-
3'dithiobis(sulfosuccinimidylpropionate) and dimethyl 3,3′-dithiopropionimidate 
dihydrochloride were both allowed to react for a total of 30 minutes at room temperature 
(25°C), the reagents were allowed to react with fesselin alone for 2 minutes before 
myosin was added. After the 30 minute reaction time the remaining unreacted cross-
linker was quenched with 10% v 250 mM Tris buffer.  
The N,N'-1,4-Phenylene-dimaleimide (PPDM) was allowed to react in a similar 
way to the amine-to-amine cross-linkers. The PPDM was allowed to react for a total of 
30 minutes at room temperature (25° C), with fesselin alone for 2 minutes before 
myosin was added. After the 30 minute reaction time the remaining unreacted cross-
linker was quenched with 10% v 20 mM DTT. 
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The UV light activated cross-linking reagents were incubated with fesselin for 30 
minutes at room temperature in light protected vessels. After 30 minutes myosin was 
added to the reaction, and allowed to incubate further for 20 minutes at 37°C. After 20 
minutes the reaction was exposed to UV light for 30 seconds using an Oriel high voltage 
UV light source to activate the cross-linker.  
With each of the reactions control experiments were performed using myosin 
alone and fesselin alone. A sample from each experiment was then run on a 5% SDS-
PAGE and stained with Coomassie blue. A sample was also taken and ran on an 
agarose/acrylamide gel with an acrylamide percentage of 3%. This was required to 
observe the large complexes formed when myosin was cross-linked. 
 
Protein co-sedimentation 
 For the sedimentation assays, smooth muscle myosin was dialyzed into a buffer 
composed of: 500 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM DTT. The 
fesselin used was dialyzed into the experimental buffer: 94 mM NaCl, 10 mM MOPS pH 
7.0, 2 mM MgCl2, 1 mM DTT. The final buffer concentration for each experiment was 
adjusted to: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM DTT. The proteins 
were mixed (1:1 molar ratio fesselin: myosin) in the centrifuge tubes and allowed to 
stand for 5 minutes before centrifugation (13,000 g, 7 minutes, 4°C). The supernatants 
and pellets were then separated and analyzed by 12% SDS-PAGE. This same 
operation was completed for the fesselin peptides, but analyzed using 15% SDS-PAGE 





The rate of dissociation of myosin from actin following rapid mixing with ATP was 
measured by light scattering on a SF20 sequential mixing stopped-flow spectrometer 
(Applied Photophysics Ltd., Leatherhead, Surrey, United Kingdom). The temperature 
was controlled with a circulating water bath at 10° C. The excitation wavelength was set 
using a monochromator using slit widths of either 0.5 or 1 mm.  
Emission wavelengths were selected with high-pass filters. Acrylodan 
fluorescence was measured with excitation at 391 nm with emission regulated by a 
Schott (Duryea, PA) GG 455 high-pass filter with a 455 nm midpoint. (2'(3')-O-(N-
methylanthraniloyl)-ATP) MANT fluorescence changes were monitored via excitation at 
366 nm and emission measured with an Oriel model 51270 high-pass filter. Pyrene 
fluorescence was measured with an excitation of 366 and emission measured with an 
Oriel model 51270 high-pass filter. Fluorescein fluorescence was measured with an 
excitation of 490 and emission measured with an Oriel model 51294 high-pass filter. 
IANBD fluorescence was measured with an excitation of 490 and emission measured 
with an Oriel model 51294 high-pass filter (Table 1). Light scattering measurements 
were taken by increasing the emission wavelength above the working range of the 









Probe λx λm λs/λc/λp1 Source 





Acrylodan 391 500 390/455/530 Oriel 51284 
IANBD 492 536 440/515/580 Oriel 51294 
MANT-ATP 366 448 340/385/480 Oriel 51270 











Fluorescent probes used. The probe names are the common names for each of the 
probes and the filters are all high-pass filters with the Oriel numbers given. λs is the stop 
band limit. λc is the midpoint of the filter (50% transmittance). λp1 is the passband limit 





The state of unphosphorylated smooth muscle myosin 
To determine the conformational state of the unphosphorylated smooth myosin 
under the experimental conditions used in these studies, we examined the rates of 
product release by myosin (ADP + Pi). This was accomplished through monitoring 
MANT-ATP fluorescence on a sequential mixing stopped-flow. MANT-ATP was 
synthesized as described by Hiratsuka (1983). The smooth myosin was mixed with 
MANT-ATP and allowed to react long enough (100 ms) for the ATP to bind and 
equilibrium to be reached between the MANT-ATP and MANT-ADP-Pi states. The 
MANT-ATP-myosin was then rapidly mixed with 100-fold excess of unlabeled ATP to 
displace the MANT-ATP and MANT-ADP-Pi (giving a decline in fluorescence). This 
gave a monoexponential decay curve with a rate of 0.66 s-1 for 500 mM KCl buffer, this 
was consistent with previously published values for stabilized 6S myosin at 600 mM KCl 
(Cross 1998 , Suzuki 1985 ). The procedure was repeated under the conditions used for 
the experiments (94 mM NaCl). The decay under these conditions fit to a biexponential 
with a k1 of 0.6 s
-1 and k2 of 0.036 s
-1. This measurement was consistent with 
equilibrium between the active 6S conformation of myosin and the inactive 10S 
conformation (figure 5). From these experiments it was clear that the myosin used 



















MANT-ATP measurements show that the myosin used was regulated properly for 
unphosphorlyated smooth myosin. This transient was collected using sequential mixing 
stopped-flow. First 0.05 μM smooth myosin was mixed with equimolar MANT-ATP. After 
0.1 seconds this was mixed with 100 fold molar excess of unlabeled ATP. The transient 
shows MANT fluorescence as a function of time as products (MANT-ATP, MANT-ADP) 
detach from myosin k1 = 0.6 s
−1, and k2 = 0.036 s
−1. Conditions: 94 mM NaCl, 10 mM 
MOPS pH 7.0, 2 mM MgCl2, 1 mM dithiolthreitol, 10°C (Reprinted with permission from 






Negative staining electron microscopy was used to visualize myosin and actin 
filaments. The technique used was modified from J. Robin Harris (2007). Carbon-coated 
Formvar nickel grids (200 mesh) were negatively charged using an EMS 100 Glow 
Discharge unit immediately prior to applying protein solutions. Solutions of myosin, 
actin, and fesselin were prepared by adding concentrated stocks to a buffer composed 
of: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, and 0.1 mM DTT. 
Proteins were first mixed at the requisite concentrations for the experiments on a 
piece of Parafilm before application to the grids. The proteins were allowed to incubate 
on the grids for 30 seconds in all cases.  
 
ATP grids 
For the experiments involving ATP the preparation of the grids required a specific 
rinse to reduce ATP-stain reactions. After the 30 second incubation with the protein the 
solution was removed by touching a piece of Whatman #1 filter paper. The grid was 
then rinsed with 50 μL of 0.1 M NH4-Acetate (pH 7.0). The rinse buffer was then 
removed with Whatman #1 filter paper to the edge of the grid.  
The ammonium acetate rinse was required to eliminate precipitation of uranyl 
phosphate from the stain (Matijević 1958).  
The rinsed grids were then stained with 1% aqueous uranyl acetate. Whatman 
#1 filter paper was placed in contact with the edge of the grid while 10 μL of 1% uranyl 
acetate was applied to the grid. After the initial stain, a further 10 μL of uranyl acetate 
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was applied to the grid surface. The stain was allowed to incubate for 45 seconds 
before removal with filter paper. The grids were air dried prior to analysis. 
 
ATP-free grids 
After the 30 second incubation with the protein the solution was removed by 
touching a piece of Whatman #1 filter paper to the edge of the grid. The grid was then 
rinsed with 50 μL of the protein buffer. The buffer rinse was then removed with 
Whatman #1 filter paper.  
The rinsed grids were then stained with 1% aqueous uranyl acetate. Whatman 
#1 filter paper was placed in contact with the edge of the grid while 10 μL of 1% uranyl 
acetate was applied to the grid. After the initial stain, a further 10 μL of uranyl acetate 
was applied to the grid surface. The stain was allowed to incubate for 45 seconds 
before removal with filter paper. The grids were air dried prior to analysis. 
 
Grid visualization 
After application of sample and staining, the grids were visualized in a JEOL 
1200EX transmission electron microscope at an accelerating voltage of 80 kV. Images 
were recorded using a SIS ImageView III CCD camera (Olympus, Tokyo, Japan). 
Examples of the resultant images can be seen throughout this thesis as well as in figure 
6 A and B. Figure 6 C and D shows a representation of how the electron beam interacts 

















The use of negative and positive stain electron microscopy gave different information for 
the same samples. A) Positive stained myosin filaments. Samples stained in this 
manner were used to measure some aspects of myosin filaments. These samples 
lacked some detail compared to negatively stained samples but gave accurate 
measurements. B) Negative stained myosin filaments. This was the major sample type 
used for the experiments. Negative staining gives more detail than positive stain in most 
cases, and allows for observation of more complex structures. C) Schematic of how 
positive stained objects interact with an electron beam. The electrons are directly 
absorbed or reflected off the sample itself. This schematic shows both a side view and a 
top down view. D) Schematic of negatively stained object. The heavy metal stain pools 
around the object and interacts with the electron beam. This gives the outline of details 
on the sample.
 Results 
The initial studies with fesselin focused on the interactions between fesselin and 
actin. It was later found that fesselin also binds to myosin. That finding initiated the 
questions that led to the present research. Knowing that fesselin bound to both actin 
and to myosin led to the question of whether fesselin can crosslink myosin and actin 
together under relaxed conditions.  That is, could a function of fesselin be to organize 
actin and myosin in a contractile competent manner? We subsequently investigated the 
ability of fesselin to stabilize myosin filaments to determine if fesselin organized all 
components of the contractile unit.  
 
Part I. The interactions of fesselin with 
actin-myosin and myosin 
 
Fesselin reduces the rate of dissociation of myosin and actin by ATP. 
Fesselin promotes actin polymerization and actin bundle formation; these 
activities suggest that fesselin helps to organize the contractile apparatus.  Fesselin 
also binds to myosin. That raised the possibility that fesselin can tether actin and 
myosin filaments to promote organization of a contractile unit.  Another protein studied 
in our laboratory, caldesmon, binds to actin (Hemric & Chalovich 1988) and to myosin 
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(Katayama et al. 1995) and does form reversible crosslinks between myosin and actin 
(Marston et al. 1992, Chalovich et al. 1997). We studied the effect of fesselin on the 
dissociation of myosin from actin following the rapid addition of ATP. 
Myosin binds very tightly to actin in the absence of ATP.  Upon the addition of 
ATP to actin-myosin the complex rapidly dissociates. This creates a challenge for cells 
because myosin needs to be in proximity to actin to permit contraction to occur and yet, 
cells have sufficient ATP to weaken the attachment of myosin to actin.  
My work started by looking at the effects of various concentrations of fesselin on 
the dissociation of actin and myosin using light scattering changes in rapid kinetics 
stopped-flow. Light scattering voltage changes monitor changes in particle size. Actin-
myosin complexes were mixed rapidly with ATP in the absence of fesselin (figure 7, 
curve 1). The rapid decrease in voltage in figure 7 shows the dissociation of myosin 
from actin caused by ATP binding. Fesselin greatly reduced the amount of filament 
dissociation on this time scale. The actin-myosin curve (curve1) was biphasic with two 
apparent rate constants: k1 = 4.2 s
−1 and k2 = 0.24 s
−1.  Addition of 0.05 μM fesselin 
(curve 4) reduced the observed rate constants to 1.6 s-1 and 0.16 s−1, respectively, or 
nearly 40% of their original values. Fesselin also reduced the amplitude, indicating the 
possibility that multiple populations of actin− fesselin− myosin filaments exist: one that 
dissociated at a rate that was around 40% of the rate of actin− myosin filaments and 
another population that did not disassemble on the experimental time scale.  
Because the process being observed in the stopped-flow was the dissociation of 
large filaments it was possible to observe the initial and final states of the process by 
44 
 
electron microscopy.  We therefore enlisted the help of Dr. Randall Renegar to 














Fesselin increased the resistance of actin-myosin filaments against ATP induced 
dissociation. Light scattering transients for 0.2 μM phalloidin-actin with 0.05 μM smooth 
myosin with varying fesselin concentrations were collected. All these transients used 2 
mM ATP final. 1) 0.0 μM fesselin, k1 = 4.2 s
−1 and k2 = 0.24 s
−1. 2) 0.0125 μM fesselin, 
k1 = 2.3 s
−1 and k2 = 0.23 s
−1. 3) 0.025 μM fesselin, k1 = 1.7 s
−1 and k2 = 0.13 s
−1. 4) 
0.05 μM fesselin, k1 = 1.6 s
−1 and k2 = 0.16 s
−1. The reduced amplitude of the transients 
with fesselin suggests that most actin−fesselin−myosin complexes were stable on this 
time scale. Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM 
dithiolthreitol, 10°C (Reprinted with permission from Kingsbury et al. copyright 2013 





Electron microscopy shows fesselin stabilizing actin and myosin against ATP 
induced dissociation 
To confirm the results of the stopped-flow experiments as well as to visualize the 
formation and stabilization of the actin− myosin complex in the presence or absence of 
fesselin, negative staining of filaments and examination using the electron microscope 
was performed. Figure 8 A shows the absence of myosin filaments on grids containing 
actin, myosin and ATP. The addition of fesselin figure 8 B stabilized the myosin 
filaments . This observation indicates that fesselin stabilizes myosin filaments, in the 
presence of ATP, and keeps those myosin filaments in close proximity to actin 
filaments.  The images used for figure 8 are representative of the random fields taken 
from the grids. In addition to random fields, the grids were further analyzed to confirm 
the absence of myosin filaments when fesselin was not present. The same 



















Electron microscopy images showing myosin filaments binding along actin filaments in 
the presence of ATP only when fesselin is present. Smooth muscle myosin and actin 
with or without fesselin were added to the grid in the presence of ATP: (A) actin−myosin 
complex with ATP and (B) actin−myosin−fesselin complex with ATP. Actin (0.2 μM) was 
used with 0.05 μM myosin and 0.1 μM fesselin. Conditions: 94 mM NaCl, 10 mM MOPS 
pH 7.0, 2 mM MgCl2, 1 mM dithiolthreitol, 10°C (Reprinted with permission from 




Fesselin stabilizes actin-myosin by tethering both proteins together and not by 
reducing the detachment rate from the specific actin-myosin interface.  
The stabilization of the actin-myosin complex by fesselin could occur because 
fesselin (i) reduces the rate of ATP binding to myosin, (ii) reduces the rate of 
detachment of actin from the specific binding site on myosin, or (iii) tethers actin and 
myosin without a direct effect on the specific actin-myosin binding site.  
To determine if fesselin was having an effect on the detachment rate of myosin 
from actin or the rate of ATP binding to myosin, experiments were performed with heavy 
meromyosin (HMM). HMM constitutes a portion of myosin that includes the ATP binding 
pocket, the actin binding domain, as well as the portion of the neck linker that holds the 
two heads of myosin together, HMM lacks a large portion of the coiled-coil tail of myosin 
(figure 9). The experiments performed with HMM were similar to those done with intact 
myosin. HMM and actin were mixed rapidly with 4 mM ATP in a stopped-flow 
spectrometer and the changes in light scattering were monitored. These studies showed 
that fesselin had a minimal effect on dissociation of HMM from actin (figure 10). A 
single-exponential process with a rate constant of 320 s−1 was observed without fesselin 
(curve 1). Addition of 0.05 μM fesselin reduced the rate constant to 230 s−1 (curve 2), 
while the rate constant was 280 s−1 (curve 3) in the presence of 0.2 μM fesselin. These 
data suggest that fesselin tethers actin and myosin together and that this tethering likely 



















Myosin can be digested with proteases into several fragments with differing functions. 
The two main fragments that have actin binding activity and ATPase activity are heavy 
meromyosin (HMM), and myosin subfragment-1 (S-1). In addition to these there is also 
myosin Rod that is composed of the entire coiled-coil domain, and light meromyosin 


















Fesselin had only slight effects on HMM dissociation from actin. Light scattering 
transients for 0.2 μM phalloidin-actin with 0.05 μM smooth heavy meromyosin (HMM) 
with varying fesselin concentrations were collected. All these transients used 2 mM ATP 
final. 1) 0.0 μM fesselin, k1 = 320 s
−1. 2) 0.05 μM fesselin, k1 = 230 s
−1. 3) 0.2 μM 
fesselin, k1 = 280 s
−1. Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 
mM dithiolthreitol, 10°C (Reprinted with permission from Kingsbury et al. copyright 2013 




To further examine the possibility of the tethering model of fesselin’s interaction 
with the actin-myosin complex pyrene-labeled actin was used. Pyrene-actin 
fluorescence has been used to monitor specific myosin binding (Geeves & Lehrer 1994, 
Crosbie et al. 1991, Franklin et al. 2012). We designed experiments that were similar to 
the light scattering studies presented earlier but, using pyrene-actin fluorescence to 
measure the rate of the myosin-actin bond breaking.  A complex of myosin and pyrene 
actin was rapidly mixed within the stopped-flow with ATP (2 mM final concentration), the 
fluorescence change that occurs correlates with the myosin-actin bond breaking. 
Figure 11 shows that the binding curves are biphasic in agreement with the 
model suggested by Trybus & Taylor (1980) and McKillop & Geeves (1991): M + A = M-
A = MA*. Fluorescence measurements measure the initial collision event while pyrene 
fluorescence measures the subsequent isomerization. The interesting result is that 
fesselin has very little effect on the pyrene fluorescence rate constant. That is, fesselin 
has little direct effect on actin-myosin bond breaking. The results of the pyrene 

















Fluorescence transients for 0.2 μM phalloidin-pyrene-actin with 0.05 μM smooth myosin 
with and without fesselin. These experiments used 2 mM ATP final. A) Linear time scale 
shows that the majority of change is very rapid, 1) 0.0 μM fesselin 2) 0.05 μM fesselin. 
B) Logarithmic time scale better displays the small differences between 1 and 2. 1) 0.0 
μM fesselin 2) 0.05 μM fesselin. Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM 




The next set of experiments utilized fluorescein labeled myosin to monitor the 
rates of ATP binding to myosin. A complex of actin and fluorescein-myosin mixture was 
rapidly mixed within the stopped-flow with ATP.  
The experiments with fluorescein-myosin were unable to show any further 
evidence for how fesselin interacts with actin and myosin because the fluorescence 
changes only monitored ATP binding. The transients collected were identical with and 
without actin present (figure 12). The fluorescence changes induced by ATP binding are 
indistinguishable from each other because actin accelerates ATP-hydrolysis and 
product release steps of the myosin cross-bridge cycle, not the ATP binding step 
directly. To provide evidence for how fesselin interacts with actin and myosin a different 
approach was required. The required method would be one that reported the rate of 

















Fluorescein-smooth myosin measurements were unable to monitor actin-myosin 
dissociation. The changes in fluorescence with fluorescein monitored ATP binding to 
myosin which showed no changes with or without actin / fesselin. Fluorescence 
transients were collected with and without actin. These experiments used 2 mM ATP 
final. 1) 0.0 μM phalloidin-actin 2) 0.2 μM phalloidin-actin. Conditions: 94 mM NaCl, 10 




The next set of experiments attempted to definitively prove that fesselin tethers 
actin and myosin together. This was accomplished by adding acrylodan labeled 
tropomyosin to the system. Tropomyosin is an actin binding protein that spans seven 
actin protomers, and changes position when myosin binds or detaches. In the case of 
acrylodan labeled tropomyosin, this change in position results in a change in 
fluorescence (Chalovich et al. 2011, Franklin et al. 2012, Borrego-Diaz & Chalovich 
2010). Experiments were first performed with unlabeled tropomyosin to determine if the 
addition of tropomyosin severely impacted the rate of dissociation of myosin from actin. 
It was found not to significantly impact the dissociation (data not shown). With this in 
mind the experiments were then performed in the same way as the light scattering 
experiments (figure 7) but with the addition of acrylodan-tropomyosin. 
The light scattering decrease was similar to that in figure 7. The light scattering 
changes over fesselin concentration it is plotted in figure 13 B as open circles (○) the 
rates were also plotted as a function of fesselin concentration for the acrylodan 
fluorescence in figure 13 B as open squares (◻). Figure 13 A shows a comparison of 
the acrylodan fluorescence for the ATP induced breakup of the actin-tropomyosin-
myosin complex in the presence and absence of fesselin. The apparent rate constants 
were 1.6 s-1 and 0.17 s-1 without fesselin and 1.4 s-1 and 0.15 s-1 with 0.25 μM fesselin. 
This is a very minimal decrease in fluorescence when compared to the changes in rate 
measured by light scattering.  
Figure 13 B shows the dependencies of light scattering and acrylodan 
tropomyosin fluorescence on fesselin concentration. Fesselin had a large effect on the 
light scattering reducing it from 2.8 s-1 to 0.5 s-1. The same could not be said for the 
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acrylodan fluorescence, which was only reduced from 1.6 s-1 to 1.4 s-1. This is to say 
that fesselin had a large effect on the disassociation of the actin-myosin complex (as 
monitored by light scattering) but had very little effect on the rate of the myosin-actin 
bond breaking. The data from the studies presented in this section definitively show the 
interaction between fesselin and actin-myosin involves a tethering of the actin and 













Fesselin had little effect on acrylodan tropomyosin fluorescence following the rapid 
addition of ATP to the actin−myosin complex. (A) Acrylodan fluorescence transients in 
the absence of fesselin (for curve 1, k1 = 1.6 s
−1 and k2 = 0.17 s
−1) and with 0.25 μM 
fesselin (for curve 2, k1 = 1.4 s
−1 and k2 = 0.15 s
−1). The fitted curves are shown as 
white lines on the data traces. (B) Plots of the apparent rate constant for the rapid 
phase, k1, vs. fesselin concentration for light scattering (○) and acrylodan fluorescence 
(□). Hyperbolic fits are shown for both processes. The best straight line fit to acrylodan 
fluorescence is also shown as a dashed line. Conditions: 94 mM NaCl, 10 mM MOPS 
pH 7.0, 2 mM MgCl2, 1 mM dithiolthreitol, 10°C (Reprinted with permission from 




Fesselin stabilizes myosin filaments 
The initial work with fesselin focused on its interactions with actin alone. This 
branched into the studies looking at actin and myosin tethering by fesselin. We also 
examined the possibility that binding of fesselin to myosin affects the stability of 
unphosphorylated myosin filaments.  
We measured the time course of disassembly of filamentous dephosphorylated 
smooth muscle myosin by ATP. The binding of ATP to unphosphorylated myosin 
dissociates filaments into inactive folded myosin monomers (Trybus et al. 1982, Ikebe et 
al. 1983). Previous studies used negative stain electron microscopy to look at the 
stabilization of dephosphorylated myosin filaments by caldesmon (Katayama et al. 
1995). Katayama et al. found that caldesmon inhibited unphosphorylated smooth 
myosin filament disassociation. We performed similar experiments to look at the effect 
of fesselin on smooth myosin filament stability; these experiments initially used stopped-
flow rather than electron microscopy. Myosin was rapidly mixed with 4 mM ATP which 
caused a rapid decrease in voltage.  
Figure 14 shows that the light scattering transition from myosin filaments to 
individual myosin was biexponential, indicating the presence of at least one 
intermediate in the disassembly process. The two apparent rate constants of 
disassembly were 1.1 and 0.1 s−1. Increasing concentrations of fesselin decreased both 
rate constants by similar amounts. At 0.2 μM fesselin, the rate constants were reduced 
to 0.35 s-1 and 0.03 s-1. The reduction in rate means the myosin filaments are not 
disassociated as rapidly. This suggests that fesselin stabilized the myosin filaments and 


















Fesselin reduces the rate of ATP-induced, smooth muscle myosin dissociation. Light 
scattering transients for 0.05 μM smooth myosin with varying fesselin concentrations 
were collected. All these transients used 2 mM ATP final. 1) 0 μM fesselin, k1 = 1.1 s
−1 
and k2 = 0.10 s
−1. 2) 0.05 μM fesselin, k1 = 0.51 s
−1 and k2 = 0.05 s
−1. 3) 0.1 μM fesselin, 
k1 = 0.42 s
−1 and k2 = 0.04 s
−1. 4) 0.2 μM fesselin, k1 = 0.35 s
−1 and k2 = 0.03 s
−1. 
Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM dithiolthreitol, 10°C 






To confirm the stabilization effects observed by stopped-flow in figure 14, the 
experiments were repeated using negative stain electron microscopy. This was 
performed using the same procedure outlined in figure 8, but in the absence of actin. 
The proteins involved were treated in the same manner as in the light scattering 
stopped-flow experiments (figures 8 and 14). ATP was added to the protein mixture 
immediately prior to application on the grid. random fields were selected to evaluate the 
effect of ATP on the myosin filaments.  Myosin filaments were counted and measured 
as seen in figure 15. In the absence of fesselin, none of the fields showed intact myosin 
filaments (figure 15 A). When fesselin was present, the myosin filaments were in a 
normal abundance and similarly sized to normal myosin filaments (myosin filaments 
without ATP or fesselin),(figure 15 B). This clearly showed similar findings to those 
described earlier (Katayama et al. 1995) with caldesmon. Fesselin indeed stabilized 



















Fesselin stabilized myosin filaments against ATP-induced disassociation shown using 
electron microscopy. (A) Smooth muscle myosin with ATP. (B) Smooth muscle 
myosin−fesselin filaments with ATP. Conditions: 0.05 μM smooth muscle myosin, 0.1 
μM fesselin, 2 mM ATP, 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM 
dithiolthreitol. ATP was added to myosin immediately before it was added to the grid. 






Fesselin increases the length and thickness of myosin filaments 
The decrease in light scattering seen in the stopped-flow experiments indicated a 
reduction in filament size, and it is known from earlier work that this is due to the 
disassembly of myosin filaments. We examined the effect of fesselin on the structure of 
myosin filaments to confirm the stabilizing effect of fesselin and to determine the 
specific structural changes to myosin filaments caused by fesselin.  
Figure 16 A shows electron micrographs of unphosphorylated myosin filaments 
in the absence of fesselin. Filaments were short and with structures similar to previously 
reported smooth muscle myosin filaments under these conditions (Trybus et al. 1987). 
The myosin filaments were noticeably larger in the presence of fesselin (figure 16 B). 
This increase in size did not appear to alter the basic structure of the filaments. 
Panels C and D are show the distribution of filament lengths and widths with and 
without fesselin. The grey lines represent the measurements in the absence of fesselin 
and the black lines represent the measurements in the presence of fesselin. The 
lengths of myosin filaments whereas increased greater than two-fold and the widths 
increased by a similar amount. 
In addition to increasing the size of myosin filaments in the presence of fesselin, 
myosin filaments were bundled together by fesselin as seen in figure 17. The 
observation of these bundles was found to occur across the fesselin-myosin grids. The 
myosin filament bundles appear to have end-to-end interactions as well as side-to-side 
interactions. The observation of myosin bundles added a very interesting aspect to 

















Electron microscopic analysis shows fesselin increases the length and width of smooth 
muscle myosin filaments. Panels A and B are representative electron micrographs of 
0.05 μM smooth muscle myosin in the absence (A) and presence (B) of 0.1 μM fesselin. 
Distributions of filament lengths (C) and widths (D) were determined by measuring the 
filaments with NIH ImageJ. These measurements were ordered by size and plotted as 
size vs. the fraction of filaments at that size. 133 filaments were measured in the 
absence of fesselin, and 126 filaments were measured in the presence of fesselin. Gray 
shaded regions are in the absence of fesselin, with an average filament length of 0.32 
μm and a width of 0.017 μm. Black lines are in the presence of fesselin, with an average 
filament length of 0.72 μm and a width of 0.048 μm. (Reprinted with permission from 




















Fesselin bundled myosin filaments into large arrays. Electron microscopy images of 
0.05 μM smooth myosin and 0.05 μM fesselin showing the buildup of a large myosin 
filament arrays. Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM 
dithiolthreitol, 10°C
 Part II. Determination of sites of 
interaction of fesselin and myosin 
 
Identification of binding sites for the fesselin-myosin interaction. 
To further understand how fesselin and myosin interact, the binding sites on 
myosin were explored using a variety of experimental procedures. The first approach 
used covalent cross-linking reagents with fesselin and myosin in an attempt to link the 
binding site on myosin to fesselin. Next sedimentation was used to analyze fesselin 
peptides responsible for binding to myosin. Finally, myosin affinity chromatography was 
used to attempt to capture the fesselin peptides that bind to the myosin. These 
approaches had only limited success and are recorded here for the benefit of future 
investigations. 
 
Covalent Cross-linking of fesselin and myosin 
Covalent cross-linking of fesselin and myosin was attempted using a variety of 
cross-linking reagents and under a variety of working conditions. The basic procedure 
involved mixing the bait protein with the cross-linking reagent for a set incubation period 
and then adding in the prey protein. The first set of experiments used myosin as the bait 
protein and fesselin as the prey. This was then reversed to use fesselin as the prey.  
Difficulties arose in the cross-linking experiments as both fesselin and myosin 
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have a tendency to self-associate. ATP was added to the mixture to minimize myosin 
self-association. Even in that condition the cross-linking remained inconclusive.  
Figure 18 shows the results from select cross-linking reagents. The reagents included: 
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), dimethyl 3,3′-
dithiopropionimidate dihydrochloride (DMDTPP), and N,N'-1,4-Phenylene-dimaleimide 
(PPDM). PPDM was the only cross-linking reagent to show potential fesselin-myosin 
complex cross-linking (lane j). The gel used for figure 18 has a glaring problem as the 
control (lane a) does not properly show fesselin and myosin together but this gel has the 
best evidence of cross-linking. (lane h) acting as the myosin control for (lane j) had 
heavy cross-linking within the stacker hence the absence of a myosin band within the 
resolving gel. When (lane i) was compared with the other results, there was some 
evidence of fesselin-fesselin cross-linking when taking into account the expected 
amount evidenced by (lane c). (lane j) shows the same amount of fesselin decrease and 
a recovery of some of the myosin band, as well as the appearance of several other 
protein bands.  
The newly apparent bands (lane j) might be a fesselin-myosin cross-linked 
product. If these studies were continued the determination of fesselin-myosin cross-
linked products would be carried out by western blot analysis with fesselin antibodies. 
After confirmation that fesselin and myosin were present in the complex the experiment 
would be repeated with a cross-linking reagent containing a retrievable tag. Using the 
tagged cross-linking reagent the fesselin-myosin complex could be isolated. The isolate 
could then be digested with proteases and the tag used again to isolate the myosin 
binding portion of fesselin before analysis by mass-spectrometry. 
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In my studies an attempt was made to better resolve the myosin cross-linked 
complexes. The cross-linking experiments were repeated using agarose-acrylamide gel 
rather than acrylamide alone (figure 18). The agarose-acrylamide gels have a final 
acrylamide matrix of 3% and the addition of agarose is required to give some stability to 
the gels. Figure 19 shows the results of various cross-linking reagents reacting with 
myosin and fesselin. In lanes e – g the experiments with N,N'-1,4-Phenylene-dimaleimide 
(PPDM) were run on the agarose-acrylamide gel.  
The gels collected (figures 18 and 19) showed that there was evidence for 
several cross-linking products of myosin and fesselin. To discern the origin for each of 
the products more controls were needed. Figure 20 shows the results of testing the 
myosin sample alone. This was done to better understand the banding patterns 
observable in the other experiments. It was clear from looking at lanes a and d that the 
myosin used for the experiments contained some cross-linked myosin and that the 
crosslinking in the sample was due to disulfide linkage. Minimizing the time out of 
reducing agents alleviated this. 
The most promising results from the cross-linking studies came from the use of 
N,N'-1,4-Phenylene-dimaleimide (PPDM). The other reagents used showed no fesselin-
myosin cross-linked products whereas the PPDM had evidence of new complexes. 
These complexes were lighter than the myosin-myosin interactions but heavier than the 

















Cross-linking of myosin and fesselin did not yield definitive results. (a) 0.05 μM Smooth 
myosin, (b) 0.05 μM smooth myosin + 1 μM 1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC), (c) 0.05 μM fesselin + 1 μM EDC (d) 0.05 μM smooth myosin + 
0.05 μM fesselin + 1 μM EDC, (e) 0.05 μM smooth myosin + 1 μM dimethyl 3,3′-
dithiopropionimidate dihydrochloride (DMDTPP), (f) 0.05 μM fesselin + 1 μM DMDTPP, 
(g) 0.05 μM myosin + 0.05 μM fesselin + 1 μM DMDTPP, (h) 0.05 μM myosin + 1 μM 
N,N'-1,4-Phenylene-dimaleimide (PPDM), (i) 0.05 μM fesselin + 1 μM PPDM, (j) 0.05 
μM myosin + 0.05 μM fesselin + 1 μM PPDM. Conditions: 85 mM NaCl, 10 mM 

















Using agarose-acrylamide gels the large myosin complexes were more readily resolved. 
(a) 0.05 μM smooth myosin + 0.05 μM fesselin, (b) 0.05 μM smooth myosin + 1 μM 3-
3'dithiobis(sulfosuccinimidylpropionate) (DTSSP), (c) 0.05 μM fesselin + 1 μM DTSSP, 
(d) 0.05 μM myosin + 0.05 μM fesselin + 1 μM DTSSP, (e) 0.05 μM myosin + 1 μM 
N,N'-1,4-Phenylene-dimaleimide (PPDM), (f) 0.05 μM fesselin + 1 μM PPDM, (g) 0.05 
μM myosin + 0.05 μM fesselin + PPDM, (h) 0.05 μM myosin + 1 μM Sulfosuccinimidyl-
2-(p-azidosalicylamido)ethyl-1,3-dithiopropionate (SASD), (i) 0.05 μM fesselin + 1 μM 
SASD, (j) 0.05 μM myosin + 0.05 μM fesselin + 1 μM SASD. Conditions: 85 mM NaCl, 

















The myosin used in the cross-linking contains cys-cys linked myosin. The myosin was 
analyzed on both agarose-acrylamide gels as well as normal acrylamide gels. (a) – (d) 
were analyzed using 3% agarose-acrylamide gel, and (e) – (h) were analyzed using 5% 
acrylamide gel. (a) 0.05 μM myosin (36 hours without dithiolthreitol (DTT)), (b) 0.05 μM 
myosin + 1 μM PPDM, (c) 0.05 μM myosin (12 hours no DTT), (d) 0.05 μM myosin + 1 
mM DTT, (e) 0.05 μM myosin (36 hours without DTT), (f) 0.05 μM myosin + 1 μM 
PPDM, (g) 0.05 μM myosin (12 hours no DTT), (h) 0.05 μM myosin + 1 mM DTT. 




Fesselin peptide co-sedimentation 
To determine what portion of fesselin was binding to myosin, co-sedimentation 
experiments were attempted. Myosin readily sediments at low speed when placed into a 
buffer that favors filament formation, under these same conditions fesselin does not 
sediment. The efficacy of this approach was first tested using intact fesselin. In the 
absence of myosin, intact fesselin did not appear in the pellet. With myosin and fesselin 
present the fesselin was found in the pellet. This was determined using SDS-PAGE as 
myosin and fesselin have a large difference in molecular weight (data not shown). 
We repeated this experiment with fragments of full length fesselin. Fesselin was 
digested with proteases (V8 protease) and the reaction was arrested with protease 
inhibitors (0.5 mM PMSF) prior to mixing with myosin. The peptide-myosin mixture was 
then pelleted using centrifugation (6000 g, 7 minutes, 4°C). The supernatants and 
pellets were analyzed separately by polyacrylamide gel electrophoresis. The gels from 
the fesselin peptide experiments did not show definitive evidence of a captured fesselin 
peptide as can be seen in figure 21. The results of this experiment are inconclusive, as 
it appears the only proteins on the gel are bands correspond to intact fesselin or 
myosin. To improve on this approach a more extensive V8 protease digestion would be 
required. 
We also tried to measure binding of fesselin fragments to a myosin affinity 
column. Myosin, HMM or S1  were covalently linked to CNBr activated sepharose 4B.   
Intact fesselin was successfully bound to affinity columns linked with whole myosin or 
myosin fragments. The main difference when using intact fesselin for each of the affinity 
column compositions was the capacity for binding. With the whole myosin a larger 
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amount of fesselin bound to the column, This was likely because of a lower affinity of 
fesselin for the myosin fragments. Triton X-100 was included in the buffer when testing 
all the affinity columns to eliminate issues of non-specific or self-interactions. 
The study was repeated using fesselin that was digested with V-8 protease, 
chymotrypsin, and subtilisin. The peptides were applied directly to the affinity columns. 
The results of the affinity purification were not definitive (figure 22). After extensive 
treatment the appearance of extremely faint bands within lanes (h) and (i) can be seen.  
The results of this show weak evidence for the capture of myosin binding 
portions of fesselin. The problem may lie in the method that fesselin uses to bind to 
targets. Fesselin adapts its shape to suit its target, which may require specific pieces of 
the protein working in conjunction. Immobilization of the myosin or myosin fragments 
may have also interfered because of binding to the resin where fesselin needs to bind. 
Another issue is that the amount recovered and ran on the gel was below the detection 
level of the staining used. If these experiments were continued a larger sample would 


















Co-sedimentation of intact smooth myosin and fesselin peptides acted to purify 
remaining intact fesselin in the samples. Samples were prepared by centrifugation at 
19,000 rpm for 7 minutes in a TLA 120.1 rotor. The samples were analyzed by SDS-
PAGE (15% acrylamide, 19: 1, acrylamide: bis-acrylamide). (a) smooth myosin + 
digested fesselin, (b) fesselin digest, (c - e) supernatant myosin + digested fesselin, (f) 
fesselin digest (g - j) pellet myosin + digested fesselin. Conditions: 94 mM NaCl, 10 mM 



















Using myosin and myosin fragments for affinity purification of fesselin fragments proved 
to be difficult. Myosin or myosin fragments were linked to affinity resin blocked and 
washed prior to running fesselin digests. The columns were used with 50 mM ionic 
strength buffer to promote binding. The chart on the right shows the absorbance 
readings for the affinity column. The fractions were then run on highly cross-linked 
acrylamide gels (15% acrylamide, 19: 1, acrylamide: bis-acrylamide). (a) human cardiac 
troponin (37 kDa TnT, 22 kDa TnI, 18 kDa TnC), (b) 100 kDa skeletal myosin 
subfragment-1, (c) 7 kDa aprotinin, (d) fesselin digest pre-column load, (e – g) wash, (h 
– j) elution from column
 Part III: Regulation of fesselin-myosin 
binding 
 
The effect of calmodulin on actin and myosin dissociation 
If fesselin promotes the assembly of contractile units it is likely that the process is 
regulated.  Indeed, the polymerization of actin by fesselin is strongly inhibited by Ca2+-
calmodulin and modestly stimulated by apo-calmodulin (Schroeter et al. 2004, 
Kolakowski et al. 2004).  Because the interaction between fesselin and actin is 
regulated by calmodulin, we wanted to test the possibility that Ca2+ and calmodulin also 
regulate actin-fesselin-myosin complex dissociation.  
To determine the effect of calmodulin on the fesselin-stabilized complex of actin-
myosin, we measured the rate of actin-myosin disassociation in the presence of 
calmodulin and ATP at various concentrations of fesselin using pyrene-actin 
fluorescence measured by stopped-flow.  
In the presence of fesselin and calmodulin the amplitude of pyrene fluorescence 
for the dissociation of myosin from pyrene-actin was decreased (figure 23 A & B). In 
contrast fesselin alone did not affect actin-myosin dissociation (figure 23 C & D). With 
the reduction in the fluorescence amplitude in the presence of calmodulin the next step 
was to observe the changes as a function of calmodulin concentration.  
The next experiments were performed with pyrene-actin with myosin and 
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fesselin. Various concentrations of calmodulin were then added to this protein mixture 
(0.2, 2, and 10 μM). The rate of ATP-induced disassociation was determined at each of 
the calmodulin concentrations using pyrene-actin fluorescence, these experiments were 
performed at 0.5 mM CaCl2 and 1 mM EGTA. This was done because calmodulin is a 
calcium binding protein and its interactions with fesselin are modulated by calcium 
(figure 24). 
The pyrene-actin fluorescence rates (measure of ATP-induced actin-myosin 
disassociation) were plotted against the calmodulin concentration. In the absence of 
calcium the rate of dissociation increased from 30.7 s-1 to 42.2 s-1 as the concentration 
of calmodulin was increased. In the presence of calcium the rate decreased from 39.5 s-
1 to 35.6 s-1 as the concentration of calmodulin was increased. Figure 23 showed that 
the presence of calmodulin increased the amplitude of pyrene fluorescence; figure 24 
shows that calmodulin also altered the rate of fluorescence change. The change in 
amplitude shows that in the presence of calmodulin a smaller fraction of the actin-
fesselin-myosin proceeded through the reaction (actin-myosin bond breaking). While 
these effects were not robust, they were consistent and showed changes induced by 















Actin-myosin dissociation induced by ATP in the presence (A, B) and absence (C, D) of 
calmodulin and presence 0.1 μM fesselin (1) and absence of fesselin (2). Fluorescence 
stopped-flow transients for 0.4 μM phalloidin-pyrene-actin with 0.1 μM smooth myosin 
and 0.4 μM calmodulin with and without fesselin mixing with 4 mM ATP. A and C) Linear 
time scale in the presence and absence of calmodulin, respectively. B and D, Logrithmic 
time scale in the presence and absence of calmodulin, respectively. Conditions: 94 mM 

















Calmodulin reduces the rate of breaking the actin-myosin bond in the pyrene-labeled 
actin-fesselin-myosin complex in the presence of 0.5 mM Ca2+ (●) but increases the rate 
in the presence of 1 mM EGTA (○).Pyrene labeled actin, smooth myosin, fesselin, and 
varying concentrations of calmodulin were rapidly mixed with ATP in the stopped flow 
device. Pyrene fluorescence was measured and the rate of decrease was plotted 
against calmodulin concentration. (0.2 μM-10 μM). The rate of dissociation decreases in 




IANBD fesselin binding to myosin fragments 
The fluorescence experiments presented earlier employed probes that could 
monitor actin changes (pyrene-actin, acrylodan-tropomyosin), or probes that could 
monitor myosin changes (fluorescein-myosin). Fluorescently labelled fesselin was 
generated in order to directly determine fesselin binding. 
Fesselin contains seven cysteine residues positioned throughout the protein; 
because fesselin is natively unfolded these cysteine residues are all readily available 
under the experimental conditions. The probe used for the labeling procedure was N,N'-
dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine (IANBD). 
The binding of S-1 and IANBD-fesselin in the presence of calmodulin (figure 25 
B) was found to be faster without Ca2+ (curve 2) with apparent rate constants of k1 = 
17.34 s-1 and k2 = 1.55 s
-1. In the presence of 0.5 mM Ca2+ (curve 1) the rates 
decreased to 8.90 s-1 and 0.374 s-1. The decrease could be due to folding of fesselin 
induced by Ca2+ -calmodulin competing with the S-1 for binding. 
The experiments were also performed with intact smooth myosin. The binding of 
myosin and IANBD-fesselin in the presence of calmodulin (figure 25 A) was found to be 
biphasic without calcium (curve 1) with a k1 = 20.75 s
−1 and k2 = 2.64 s
−1. With 0.5 mM 
Ca2+ present (curve 2) the first apparent rate constant remained much the same k1 = 
19.04 s−1 while the second increased by greater than 4-fold to k2 = 11.23 s
−1. The 
presence of Ca2+ -calmodulin (curve 2) caused the voltage to peak then decrease at 
around 0.15 seconds, this pattern was absent with apo-calmodulin. 
The effects of calmodulin observed by IANBD-fesselin fluorescence appear to be 
inhibition of myosin bundling. When this experiment is monitored by light scattering the 
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bundling of myosin by fesselin is regulated by calcium (figure 26). The fluorescence 
changes induced by Ca2+ -calmodulin could be explained as a folding change (this 
folding was seen as a fluorescence change represented as F* going to F**) in the 
fesselin due to calmodulin binding (figure 27).  
The binding of fesselin to myosin or S-1 was measured across multiple myosin 
concentrations by stopped-flow in the presence of calcium. The resulting rates were 
then plotted against total concentration of myosin or S-1 in the experiment (figure 28). 
The rates plotted were the first rate process as the concentration of myosin or S-1 had 
the most effect on it. From the plots of the rate versus the concentration, the affinity of 
the IANBD-fesselin for myosin was estimated. The affinity for myosin was reduced from 
0.5 μM as described earlier (Schroeter et al. 2008) to nearly 2 μM. This finding shows 














Binding of IANBD-labeled fesselin to myosin in the presence of calmodulin. IANBD 
labeled fesselin and calmodulin were rapidly mixed with either myosin and calmodulin 
(A) or myosin subfragment-1 (S-1) and calmodulin (B) in the presence of 1 mM EGTA 
(1)  or 0.5 mM CaCl2 (2) A) Final concentrations, 0.05 μM fesselin,  0.5 μM myosin, 0.05 
μM calmodulin, 1) 1 mM EGTA, k1 = 20.75 s
−1 and k2 = 2.64 s
−1, 2) 0.5 mM CaCl2, k1 = 
19.04 s−1 and k2 = 11.23 s
−1.B) Final conditions, 0.05 μM fesselin, 0.5 μM S-1, 0.05 mM 
calmodulin, 1) 0.5 mM CaCl2, k1 = 8.90 s−1 and k2 = 0.374 s−1, 2) 1 mM EGTA, k1 = 
17.34 s−1 and k2 = 1.55 s−1. Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM 


















Light scattering measurements of myosin bundling by IANBD-fesselin in the presence of 
calmodulin. For these experiments the final protein concentrations were: 0.05 μM 
fesselin, 0.5 μM myosin and 0.05 μM calmodulin. Curve 1 is in the absence of Ca2+ (1 
mM EGTA).Curve 2 is the bundling in the presence of 0.5 mM CaCl2 the increase in 
signal is likely due to myosin bundle formation. The bundling of fesselin appears to be 






















Scheme used for the modeling of IANBD-fesselin fluorescence changes induced by 
Ca2+ -calmodulin. The binding of fesselin and myosin causes a fluorescence change. 
The differences with and without Ca2+ can be explained with two fluorescence steps (F* 














Using IANBD-fesselin the binding kinetics to both smooth myosin subfragment-1 (S-1) 
and intact smooth myosin were observed. A) IANBD-fesselin + S-1 across various 
concentrations of S-1. B) IANBD-fesselin + myosin across various concentrations of 
myosin. The binding of fesselin appears to have been weakened (<2 μM) compared to 
previously measured values (0.5 μM). Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 
mM MgCl2, 1 mM dithiolthreitol, 10°
 Discussion 
A basic requirement for muscle contraction is the organization of actin and 
myosin filaments. For productive contraction to occur actin filaments need to be bundled 
and organized to transmit the force produced by myosin. Our lab and others have 
already found that fesselin polymerizes F-actin filaments (Beall et al. 2001, Leinweber et 
al. 1999), and organizes the filaments into bundles (Schroeter et al. 2013). It was also 
found that the polymerization of actin by fesselin was regulated by Ca2+ -calmodulin 
(Schroeter et al. 2004, Kolakowski et al. 2004).  
We have shown here that in addition to the interactions with actin, fesselin also 
plays an important role in myosin organization. For proper force production myosin must 
be in filamentous form and in contact with actin filaments. We found that fesselin 
stabilized unphosphorylated smooth myosin against ATP-induced disassociation. In 
addition to stabilizing myosin, fesselin was also found to enhance myosin filament 
length and width as well as organize the filaments into bundles. We have also shown 
here that fesselin organized actin and myosin filaments by tethering the actin and 
myosin filaments together.  
In addition to the organization of actin and myosin filaments the studies 
presented here found that the interactions between fesselin and myosin are regulated 
similarly to the actin-fesselin interactions. It was found that the binding of fesselin to 
myosin was regulated through Ca2+ -calmodulin. The regulation of both the fesselin-
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actin and fesselin-myosin activities by calmodulin places fesselin into the role of 
organizing smooth muscle proteins for contraction.  
 
Fesselin stabilizes myosin 
The studies presented here showed that fesselin stabilizes unphosphorylated 
smooth myosin filaments. Stabilization of smooth myosin filaments is an important 
interaction because in the case of unphosphorylated smooth myosin, the filaments 
disassociate when they come in contact with ATP (Suzuki et al. 1978, Trybus et al. 
1982, Ikebe et al. 1983). We showed that when fesselin is present the smooth myosin 
filaments were more resilient to this disassociation.  
The stability of unphosphorylated myosin filaments was initially tested using 
stopped-flow kinetic measurements. As the concentration of fesselin was increased the 
rate of myosin filament break up slowed. Light scattering traces were collected by 
stopped-flow and the rate of ATP-induced disassociation was determined. It was 
observed that the rate of ATP-induced disassociation was not only slower in the 
presence of fesselin but also ended at higher amplitude. The rate decrease is due to 
fesselin slowing of the myosin break down. The higher amplitude could be due to 
multiple populations of myosin that break apart at different rates. The stopped-flow 
measurements were then confirmed using electron microscopy. The confirmation came 
when in the presence of fesselin, myosin filaments were present on the ATP treated 




In addition to stabilizing myosin filaments, fesselin was also found to enhance 
and organize the smooth myosin filaments. The enhancement of myosin filament length 
and width was observed by electron microscopy in the absence of ATP. Further 
examination of the electron microscopy grids found that, in the presence of fesselin, the 
smooth myosin filaments also formed large bundles. These myosin filament bundles are 
clearly constructed of individual smooth myosin filaments interacting in an end-to-end 
and side-to-side manner. The increased size and bundling of myosin filaments when 
taken with the stabilization of myosin gives more insight into the changes in amplitude 
noted in the stopped-flow experiments. The increased amplitude is likely from the larger 
myosin filaments at the starting point, showing indeed there are several populations of 
myosin filaments.  
The findings that fesselin stabilizes unphosphorylated myosin and enhances the 
filament dimensions have been seen in other proteins, such as telokin (Kudryashov et 
al. 2002) and caldesmon (Katayama et al. 1995) in smooth muscle. Both caldesmon 
and telokin interact with the myosin to promote filament formation. This was not seen 
with fesselin. The filaments formed in the presence of caldesmon and telokin are larger 
than the average myosin filament (Katayama et al. 1995), but the interactions of these 
proteins has not been shown to bundle myosin filaments as fesselin has been shown 
here to do. Additionally the increase in smooth myosin filament size by caldesmon was 
to a lesser extent than fesselin. With this information it is clear that fesselin is a potent 
myosin organizing protein in smooth muscle. 
 
Fesselin organizes actin-myosin 
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With the previous studies showing that fesselin organized both actin and myosin 
filaments separately we set about testing the ability of fesselin to organize actin and 
myosin filaments together. As noted previously, for muscle contraction to be possible 
actin and myosin filaments need to be associated into an organized complex. The 
results presented here show that fesselin organizes F-actin and myosin filaments 
together and holds them in close proximity to each other. 
The initial evidence for fesselin cross-linking of actin and myosin by fesselin was 
noted in the light scattering experiments; the ATP-induced disassociation of the actin-
myosin complex was slowed in the presence of fesselin. The slowing of the complex 
break down is clearly due to fesselin interacting with actin and myosin. The actin-myosin 
complex cross-linking by fesselin was further examined using electron microscopy. The 
electron microscopy experiments showed that in the presence of fesselin, myosin 
filaments remain in proximity to the F-actin filaments even in the presence of ATP. 
The next finding was that the cross-linking of F-actin and myosin by fesselin was 
a tethering effect. The binding to both proteins by fesselin did not inhibit normal 
breaking of the myosin-actin bond by ATP. The tethering of F-actin and myosin by 
fesselin is schematically laid out in figure 29. Actin (A) and myosin (M) are associated 
with each other, fesselin (F) binds to both the actin and myosin. ATP binding to myosin 
causes the actin-myosin bond to break. The tethering come into play as the actin and 
myosin are being held together through the fesselin. The fesselin-myosin bond then 
breaks allowing the complex to fully disassociate. 
The first evidence for tethering actin and myosin by fesselin was observed in the 
stopped-flow experiments examining heavy meromyosin (HMM) detachment from actin 
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by ATP. These experiments showed that fesselin did not significantly slow the 
detachment rate of HMM. The effects of fesselin on HMM are important as it shows the 
binding of fesselin is likely strongest in the filament forming portion of myosin (the 
portion HMM lacks), this experiment further showed that fesselin did not impact the rate 
of the actin-myosin bond breaking. The next experiments were performed using pyrene 
labeled actin to more directly monitor the rate of the myosin-actin bond breaking. The 
pyrene-actin experiments showed very little change in the fluorescence rate with or 
without fesselin. From this finding it can be concluded to mean that fesselin does not 
slow the breaking of the actin-myosin bond.  
The definitive proof for the tethering interaction of fesselin came when acrylodan 
tropomyosin was added to the actin-myosin complex. This study used acrylodan 
fluorescence to monitor the myosin-actin bond in addition to light scattering 
measurements. The acrylodan-tropomyosin studies showed that the light scattering 
rates were decreased as shown earlier, but the fluorescence was fairly constant across 
fesselin concentration. The decrease in the rate of light scattering showed that the 
particle (tropomyosin-actin-fesselin-myosin) was disassociating more slowly, while the 
fluorescence (acrylodan-tropomyosin) showed that the rate of the actin-myosin bond 
breaking was the same with and without fesselin present. 
Similar cross-linking of F-actin to myosin has been found with other proteins 
across muscle types. These include myosin-binding protein-C in striated muscle (Luther 
et al. 2011) as well as caldesmon (Ikebe et al. 1988, Marston et al. 1992, Chalovich et 
al. 1988) and calponin (Roman et al. 2013) in smooth muscle. Comparatively the 
tethering of F-actin and myosin by fesselin is far more robust than that of caldesmon or 
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calponin. Dr. Chalovich and Dr. Schroeter performed stopped-flow experiments to 
directly compare the effects of caldesmon and fesselin. The results of this study can be 
seen in figure 30.  
The direct linking of actin and myosin fills a vital role within muscle. In the case of 
smooth muscle and non-muscle, tethering of the myosin and actin together can fill many 
of the gaps that exist because there is not a highly defined sarcomere structure as there 
is in striated muscle. In striated muscle the tethering activity of myosin-binding protein-C 
is thought to tie the movement of the thick and thin filaments together coordinating the 
contraction more efficiently (Luther et al. 2011). The results presented here show that 


























Schematic representation of the actin-fesselin-myosin interaction. Fesselin tethers actin 
and myosin together. Upon the binding of ATP to myosin, the myosin-actin bond breaks. 
The fesselin acts as a tether holding the actin and myosin in proximity until the fesselin 





The activities of fesselin are regulated by calmodulin 
In addition to the findings that fesselin stabilized myosin filaments and organized 
actin and myosin filaments together it was further found that the binding of fesselin to 
myosin was regulated by calmodulin. In addition to altering the binding of fesselin and 
myosin, the myosin bundling activity of fesselin was inhibited in the presence of apo-
calmodulin. These findings place fesselin within the Ca2+-signaling pathway presented 
in earlier. Fesselin would fit in after calmodulin binds calcium and would branch off to 
alter fesselin interactions with actin and myosin in preparation for contraction (figure 30). 
Previously published data observed that Ca2+ -calmodulin inhibited the ability for 
fesselin to polymerize F-actin (Schroeter 2004). The findings here show the opposite 
effect on fesselin-myosin interactions. The calmodulin regulation of fesselin may act as 
a switch to promote myosin bundling when calcium is high and promote actin 
polymerization when calcium is low. 
The first evidence for calmodulin regulation of fesselin-myosin interactions was 
found when calmodulin was added to pyrene-actin-myosin stopped-flow experiments. 
When calmodulin was present with fesselin the pyrene-actin fluorescence decreased in 
amplitude, meaning that Ca2+ -calmodulin caused a smaller portion of the reaction to 
progress normally. This result was then compared with the observations made of 
pyrene-actin fluorescence without calmodulin. The results of these experiments showed 
that in the presence of calmodulin and fesselin the rate of the myosin-actin bond 
breaking was slowed.  After this observation the concentration dependence of 
calmodulin was tested. The rates of pyrene fluorescence were plotted against 
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calmodulin concentration. From this set of experiments it would appear that in the 
presence of Ca2+ -calmodulin, fesselin inhibits the disassociation of actin-myosin 




















A simplified schematic of smooth muscle regulation with the additional fesselin-myosin 
regulation. Calcium channels on the cell allow intracellular calcium ion increase leading 
eventually to contraction through interaction of Ca2+ -calmodulin and MLCK. In addition 
to MLCK, Ca2+ calmodulin appears to interact directly with fesselin and promote the 






Additional evidence for the calmodulin regulation of fesselin came when looking 
at the binding of IANBD labeled fesselin to myosin. It was found that Ca2+ -calmodulin 
caused a change in the folding of fesselin upon binding to myosin. These binding events 
can be seen in the fluorescence changes of the IANBD probe the initial rise in 
fluorescence shows that the probes on the fesselin are being protected.  
The evidence for the effect of Ca2+ -calmodulin on the bundling of myosin by 
fesselin was observed when fluorescent fesselin was added to myosin in the presence 
of calmodulin. When Ca2+ was present the signal increased steadily indicating the 
formation of myosin bundles. When Ca2+ was absent the signal remained low. These 
measurements were taken in conjunction with the fluorescence measurements showing 
fesselin was still binding the myosin in the absence of Ca2+, but not bundling myosin 
filaments.  
There are a large variety of proteins that are regulated through calcium or 
calmodulin. The regulation of smooth myosin is an example of this interaction, where 
calmodulin stimulates phosphorylation and activation of the myosin. The experiments 
presented here have shown that the interactions between fesselin and myosin are 
similarly promoted by Ca2+ -calmodulin. 
 
Conclusions 
The work presented in this discussion reveals that fesselin plays an important 
role in the organization of actin and myosin filaments, that fesselin stabilizes myosin 
filaments and has its activity regulated by calmodulin. These activities are summarized 
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in figure 31 and fit fesselin within the overall regulation of smooth muscle making it a 
critical protein within the cell.  
 
Future Directions 
The studies presented here have shown the interactions of fesselin with smooth 
muscle myosin. To build upon this, it is important to look at the interactions between 
fesselin and non-muscle myosin isoforms. This direction is important to definitively 
understand the role that fesselin plays in cancer cell metastasis.  
Another research direction is to define the points of contact between fesselin and 
myosin. This was attempted in the studies presented here but was unsuccessful despite 
numerous attempts. To accomplish this task an expressible form of fesselin needs to be 
generated to more easily control the fragments used for the experiments. 
Further studies can also be done involving the regulation of fesselin’s activity by 
calmodulin. These experiments would look at the interaction of fesselin to the other 
known binding partners in the presence and absence of calmodulin. It is likely that many 


















Proposed activities of fesselin with actin and myosin. A) Fesselin’s known interactions 
with actin. Fesselin binds to actin and accelerates the polymerization, the acceleration is 
regulated by Ca2+ -calmodulin. The fesselin further interacts with actin filaments and 
bundles them. B) The proposed interaction between fesselin and actin-myosin with the 
added regulation by Ca2+ -calmodulin. C) The proposed interactions of fesselin with 
myosin. This proposed activity is based on interactions of similar proteins and the 
affinity of fesselin for myosin.  
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 Appendix A: Reduction of actin-myosin dissociation by caldesmon compared to 
fesselin 
To determine the effect of fesselin on the stability of actin-myosin Dr. Joseph 
Chalovich performed ATP chase experiments. 0.2 mM ATP was rapidly mixed with 
actin-myosin complexes in a stopped-flow spectrometer and the dissociation kinetics 
were followed using light scattering. Actin-myosin was rapidly mixed with ATP as seen 
in figure 30 (curve 1). This experiment monitored the changes in the scattered light to 
determine the changes in particle size.  
The initial experiment with actin and myosin was repeated with the addition of 1 
μM caldesmon (curve 2). The figure shows that the effect of adding the caldesmon is a 
decrease in the rate of light scattering change. This was interpreted as a decrease in 
the dissociation of the myosin from actin. Caldesmon reduced the rate of dissociation to 
10% of the initial rate.  The same experiment was then repeated with 1 μM fesselin 
added to the actin and myosin (curve 3). When this is compared with the actin-myosin 
alone there is on the order of a thousand-fold decrease in the rate. From this initial 
observation it was clear that fesselin had a much greater effect on actin and myosin 












Fesselin slows the dissociation of actin-myosin by ATP to a greater extent than 
caldesmon. 1) 0.2 μM phalloidin-actin with 0.05 μM smooth myosin + 0.2 mM ATP 2) 
0.2 μM phalloidin-actin with 0.05 μM smooth myosin and 0.2 μM caldesmon + 0.2 mM 
ATP 3) 0.2 μM phalloidin-actin with 0.05 μM smooth myosin with 0.2 μM fesselin + 0.2 
mM ATP. These transients were collected on a stopped-flow measuring light scattering. 
Conditions: 94 mM NaCl, 10 mM MOPS pH 7.0, 2 mM MgCl2, 1 mM dithiolthreitol, 10°C 
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